Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 of the European Parliament and of the Council (Text with EEA relevance) (revoked)
EU Regulation No 507/2006 · Adopted 29 March 2006 · Extends to United Kingdom
Commission Regulation (EC) No 507/2006
of 29 March 2006
on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 of the European Parliament and of the Council
(Text with EEA relevance) (revoked)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
- F1
Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(k) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)
Contents
- 1Subject matter Repealed
- 2Scope Repealed
- 3Requests or proposals Repealed
- 4Requirements Repealed
- 5Specific obligations Repealed
- 6Renewal Repealed
- 7Marketing authorisation not subject to specific obligations Repealed
- 8Product Information Repealed
- 9Periodic safety update reports Repealed
- 10Agency advice prior to marketing authorisation application Repealed
- 11Guidelines Repealed
- 12Transitional provision Repealed
- 13Entry into force Repealed
- Signature
1Subject matterF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2ScopeF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Requests or proposalsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4RequirementsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Specific obligationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6RenewalF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7Marketing authorisation not subject to specific obligationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Product InformationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9Periodic safety update reportsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Agency advice prior to marketing authorisation applicationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11GuidelinesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12Transitional provisionF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13Entry into forceF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Signature
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .